IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 86 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $438,672 | -38.0% | 29,600 | -20.1% | 0.01% | -52.9% |
Q4 2021 | $708,000 | -33.0% | 37,066 | -13.5% | 0.02% | -41.4% |
Q3 2021 | $1,057,000 | -14.5% | 42,874 | -9.7% | 0.03% | -27.5% |
Q2 2021 | $1,236,000 | +904.9% | 47,471 | +183.5% | 0.04% | +53.8% |
Q2 2017 | $123,000 | – | 16,746 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |